Cidara Therapeutics Newsroom

Cidara Therapeutics' CD388: Promising Influenza Prevention Drives Buy Rating

TipRanksNov 11 06:33 ET

H.C. Wainwright Maintains Cidara Therapeutics(CDTX.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsNov 11 06:31 ET

Cidara Therapeutics Analyst Ratings

BenzingaNov 8 06:33 ET

Guggenheim Initiates Coverage On Cidara Therapeutics With Buy Rating, Announces Price Target of $33

BenzingaNov 8 06:32 ET

Guggenheim Initiates Cidara Therapeutics(CDTX.US) With Buy Rating, Announces Target Price $33

Moomoo NewsNov 8 06:31 ET

Needham Maintains Cidara Therapeutics(CDTX.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsNov 8 05:37 ET

Cidara Therapeutics Analyst Ratings

BenzingaOct 22 07:18 ET

H.C. Wainwright Maintains Cidara Therapeutics(CDTX.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsOct 22 06:31 ET

Promising Results of CD388 Lead to Buy Rating for Cidara Therapeutics

TipRanksOct 22 06:27 ET

H.C. Wainwright Maintains Cidara Therapeutics(CDTX.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsSep 16 07:31 ET

Cidara Therapeutics Analyst Ratings

BenzingaSep 16 06:35 ET

Cidara Therapeutics Analyst Ratings

BenzingaAug 14 05:41 ET

Needham Maintains Cidara Therapeutics(CDTX.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsAug 14 05:32 ET

Cidara Therapeutics Analyst Ratings

BenzingaJun 20 13:31 ET

Cidara Therapeutics Analyst Ratings

BenzingaMay 16 07:08 ET

Buy Rating Justified by Cidara Therapeutics' Upcoming Clinical Trials and Expanding Oncology Pipeline

TipRanksMay 16 06:30 ET

Cidara Therapeutics Analyst Ratings

BenzingaApr 25 10:34 ET

Cidara Therapeutics Analyst Ratings

BenzingaApr 23 08:54 ET

Cidara Therapeutics Analyst Ratings

BenzingaApr 8 14:21 ET

HC Wainwright & Co. Maintains Buy on Cidara Therapeutics, Maintains $6 Price Target

BenzingaApr 8 14:20 ET